pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4251 |
Genomic Coordinates | chr1: 3127975 - 3128035 |
Description | Homo sapiens miR-4251 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4251 | |||||||||||||||
Sequence | 35| CCUGAGAAAAGGGCCAA |51 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | SOLiD | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | NCOA3 | ||||||||||||||||||||
Synonyms | ACTR, AIB-1, AIB1, CAGH16, CTG26, KAT13B, RAC3, SRC-3, SRC3, TNRC14, TNRC16, TRAM-1, bHLHe42, pCIP | ||||||||||||||||||||
Description | nuclear receptor coactivator 3 | ||||||||||||||||||||
Transcript | NM_001174087 | ||||||||||||||||||||
Other Transcripts | NM_001174088 , NM_006534 , NM_181659 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on NCOA3 | |||||||||||||||||||||
3'UTR of NCOA3 (miRNA target sites are highlighted) |
>NCOA3|NM_001174087|3'UTR 1 CATCTCTGCACCAGGACCTCTTAAGGAAACCACTGTACAAATGACACTGCACTAGGATTATTGGGAAGGAATCATTGTTC 81 CAGGCATCCATCTTGGAAGAAAGGACCAGCTTTGAGCTCCATCAAGGGTATTTTAAGTGATGTCATTTGAGCAGGACTGG 161 ATTTTAAGCCGAAGGGCAATATCTACGTGTTTTTCCCCCCTCCTTCTGCTGTGTATCATGGTGTTCAAAACAGAAATGTT 241 TTTTGGCATTCCACCTCCTAGGGATATAATTCTGGAGACATGGAGTGTTACTGATCATAAAACTTTTGTGTCACTTTTTT 321 CTGCCTTGCTAGCCAAAATCTCTTAAATACACGTAGGTGGGCCAGAGAACATTGGAAGAATCAAGAGAGATTAGAATATC 401 TGGTTTCTCTAGTTGCAGTATTGGACAAAGAGCATAGTCCCAGCCTTCAGGTGTAGTAGTTCTGTGTTGACCCTTTGTCC 481 AGTGGAATTGGTGATTCTGAATTGTCCTTTACTAATGGTGTTGAGTTGCTCTGTCCCTATTATTTGCCCTAGGCTTTCTC 561 CTAATGAAGGTTTTCATTTGCCATTCATGTCCTGTAATACTTCACCTCCAGGAACTGTCATGGATGTCCAAATGGCTTTG 641 CAGAAAGGAAATGAGATGACAGTATTTAATCGCAGCAGTAGCAAACTTTTCACATGCTAATGTGCAGCTGAGTGCACTTT 721 ATTTAAAAAGAATGGATAAATGCAATATTCTTGAGGTCTTGAGGGAATAGTGAAACACATTCCTGGTTTTTGCCTACACT 801 TACGTGTTAGACAAGAACTATGATTTTTTTTTTTAAAGTACTGGTGTCACCCTTTGCCTATATGGTAGAGCAATAATGCT 881 TTTTAAAAATAAACTTCTGAAAACCCAAGGCCAGGTACTGCATTCTGAATCAGAATCTCGCAGTGTTTCTGTGAATAGAT 961 TTTTTTGTAAATATGACCTTTAAGATATTGTATTATGTAAAATATGTATATACCTTTTTTTGTAGGTCACAACAACTCAT 1041 TTTTACAGAGTTTGTGAAGCTAAATATTTAACATTGTTGATTTCAGTAAGCTGTGTGGTGAGGCTACCAGTGGAAGAGAC 1121 ATCCCTTGACTTTTGTGGCCTGGGGGAGGGGTAGTGCTCCACAGCTTTTCCTTCCCCACCCCCCAGCCTTAGATGCCTCG 1201 CTCTTTTCAATCTCTTAATCTAAATGCTTTTTAAAGAGATTATTTGTTTAGATGTAGGCATTTTAATTTTTTAAAAATTC 1281 CTCTACCAGAACTAAGCACTTTGTTAATTTGGGGGGAAAGAATAGATATGGGGAAATAAACTTAAAAAAAAATCAGGAAT 1361 TTAAAAAAACGAGCAATTTGAAGAGAATCTTTTGGATTTTAAGCAGTCCGAAATAATAGCAATTCATGGGCTGTGTGTGT 1441 GTGTGTATGTGTGTGTGTGTGTGTGTATGTTTAATTATGTTACCTTTTCATCCCCTTTAGGAGCGTTTTCAGATTTTGGT 1521 TGCTAAGACCTGAATCCCATATTGAGATCTCGAGTAGAATCCTTGGTGTGGTTTCTGGTGTCTGCTCAGCTGTCCCCTCA 1601 TTCTACTAATGTGATGCTTTCATTATGTCCCTGTGGATTAGAATAGTGTCAGTTATTTCTTAAGTAACTCAGTACCCAGA 1681 ACAGCCAGTTTTACTGTGATTCAGAGCCACAGTCTAACTGAGCACCTTTTAAACCCCTCCCTCTTCTGCCCCCTACCACT 1761 TTTCTGCTGTTGCCTCTCTTTGACACCTGTTTTAGTCAGTTGGGAGGAAGGGAAAAATCAAGTTTAATTCCCTTTATCTG 1841 GGTTAATTCATTTGGTTCAAATAGTTGACGGAATTGGGTTTCTGAATGTCTGTGAATTTCAGAGGTCTCTGCTAGCCTTG 1921 GTATCATTTTCTAGCAATAACTGAGAGCCAGTTAATTTTAAGAATTTCACACATTTAGCCAATCTTTCTAGATGTCTCTG 2001 AAGGTAAGATCATTTAATATCTTTGATATGCTTACGAGTAAGTGAATCCTGATTATTTCCAGACCCACCACCAGAGTGGA 2081 TCTTATTTTCAAAGCAGTATAGACAATTATGAGTTTGCCCTCTTTCCCCTACCAAGTTCAAAATATATCTAAGAAAGATT 2161 GTAAATCCGAAAACTTCCATTGTAGTGGCCTGTGCTTTTCAGATAGTATACTCTCCTGTTTGGAGACAGAGGAAGAACCA 2241 GGTCAGTCTGTCTCTTTTTCAGCTCAATTGTATCTGACCCTTCTTTAAGTTATGTGTGTGGGGAGAAATAGAATGGTGCT 2321 CTTATCTTTCTTGACTTTAAAAAAATTATTAAAAACAAAAAAAAAATAAATTTTTTTGCAATCCTTTCCTCAGACCTGGC 2401 TCCAGGCTAACTGGAAGGCAGCACTCCCTTTTTTATATAGTAGAAAAATGAAGTTTATTATAAGTTTTTATATTTTCTAC 2481 TTGTTCATTTGGTGCAAACTCAAGATTTCTTTTAATAGGTGCAGTCTTTGAGATAATTTGTTTTTACCTGTATTGCCCTT 2561 TATCTTTTTTAGGTAATTCTTTGTACTCCTGCTGTCTACCTCTCCTCACACCCCAGCACCCCCCATTTTTTCAAACCTTG 2641 GTATCTGTTGGGTGAACAGTATAATCTTTTCATCTGCTTTTAGAATGTGGGATATTTCCAGTACCTACTTTTTTTTTTTT 2721 TTTTTGCTGAATCCAAAGATATATAAATAAAATATATATATTTTATAAAGATCAGAATGATATAAAGGAGATACATGTTT 2801 CTTCCTTTAAAAAATAAACGGAAGTTACATTGTTAATGTTCATATTATGATGCCACTTTTCTAAACTGCATCTGGATTGA 2881 AAGGTGTAAATATCAATAACAGTGCTACTTAGTTATCAGTATTTAATATCTGAGGTGAGTTGGGGGTATCTATATTAGGG 2961 GTAGGGTATTACAGAAGATAATTGGCTTGATGTCCTAGAAGTTCTTTGATCCAGAGGTGGGTGCAGCTGAAAGTAAACAG 3041 AATGGATTGCCAGTTACATGTATGCCTGCCCAGTTCCCTTTTTATTTGCAGAAGCTGTGAGTTTTGTTCACAATTAGGTT 3121 CCTAGGAGCAAAACCTCAAGGATTGATTTATTGTTTTCAACTCCAAGGCACACTGTTAATAAACGAGCAGGGTGTTTTCT 3201 CTCTTCCTTTCTAATATATGGAGTTTCGAAGAATAAAATATGAGAGCAATATTTAAATTCTCAGGAATTGACTTATACTC 3281 TTGAGAATGAATTCAGTTTCAATCAAGTTTACATTATGTTGCTTAAAAAAATAGAAATTATTCTTTATCTTGCAAAGAAT 3361 TGAAACCACATGAAATGACTTATGGGGGATGGTGAGCTGTGACTGCTTTGCTGACCATTTTGGATGTCATTGTAAATAAA 3441 GGTTTCTATTTAAAATTGGA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | MCF7 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRR1045082. RNA binding protein: AGO2. Condition:Untreated
... - Farazi TA; Ten Hoeve JJ; Brown M; et al., 2014, Genome biology. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Farazi TA; Ten Hoeve JJ; Brown M; et al. - Genome biology, 2014
BACKGROUND: Various microRNAs (miRNAs) are up- or downregulated in tumors. However, the repression of cognate miRNA targets responsible for the phenotypic effects of this dysregulation in patients remains largely unexplored. To define miRNA targets and associated pathways, together with their relationship to outcome in breast cancer, we integrated patient-paired miRNA-mRNA expression data with a set of validated miRNA targets and pathway inference. RESULTS: To generate a biochemically-validated set of miRNA-binding sites, we performed argonaute-2 photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (AGO2-PAR-CLIP) in MCF7 cells. We then defined putative miRNA-target interactions using a computational model, which ranked and selected additional TargetScan-predicted interactions based on features of our AGO2-PAR-CLIP binding-site data. We subselected modeled interactions according to the abundance of their constituent miRNA and mRNA transcripts in tumors, and we took advantage of the variability of miRNA expression within molecular subtypes to detect miRNA repression. Interestingly, our data suggest that miRNA families control subtype-specific pathways; for example, miR-17, miR-19a, miR-25, and miR-200b show high miRNA regulatory activity in the triple-negative, basal-like subtype, whereas miR-22 and miR-24 do so in the HER2 subtype. An independent dataset validated our findings for miR-17 and miR-25, and showed a correlation between the expression levels of miR-182 targets and overall patient survival. Pathway analysis associated miR-17, miR-19a, and miR-200b with leukocyte transendothelial migration. CONCLUSIONS: We combined PAR-CLIP data with patient expression data to predict regulatory miRNAs, revealing potential therapeutic targets and prognostic markers in breast cancer.
LinkOut: [PMID: 24398324]
|
CLIP-seq Support 1 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_181659 | 3UTR | CUCUUCCUUUCUAAUAUAUGGAGUUUCGAAGAAUAAAAUAUGAGAGCAAUAUUUAAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903835 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_c |
Location of target site | NM_181659 | 3UTR | AAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903836 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_a |
Location of target site | NM_181659 | 3UTR | AGCAAUAUUUAAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_181659 | 3UTR | AGCAAUAUUUAAAUUCUCAGGAAUUGACUUAUACUCUUGAGAAUGAAUUCA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset SRR1045082 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | MCF7 / Untreated |
Location of target site | ENST00000341724.6 | 3UTR | CAAUAUUUAAAUUCUCAGGAAUUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 24398324 / SRX388831 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
98 hsa-miR-4251 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT056156 | OTUD1 | OTU deubiquitinase 1 | 2 | 2 | ||||||||
MIRT080004 | MYL12B | myosin light chain 12B | 2 | 2 | ||||||||
MIRT080407 | ONECUT2 | one cut homeobox 2 | 2 | 2 | ||||||||
MIRT081901 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT090342 | SEC61A1 | Sec61 translocon alpha 1 subunit | 2 | 8 | ||||||||
MIRT096824 | ZSWIM6 | zinc finger SWIM-type containing 6 | 2 | 4 | ||||||||
MIRT140185 | CHAC1 | ChaC glutathione specific gamma-glutamylcyclotransferase 1 | 2 | 2 | ||||||||
MIRT149716 | LDLR | low density lipoprotein receptor | 2 | 6 | ||||||||
MIRT205293 | STK11IP | serine/threonine kinase 11 interacting protein | 2 | 2 | ||||||||
MIRT213265 | REST | RE1 silencing transcription factor | 2 | 6 | ||||||||
MIRT254069 | BACH1 | BTB domain and CNC homolog 1 | 2 | 2 | ||||||||
MIRT256251 | ANKRD33B | ankyrin repeat domain 33B | 2 | 2 | ||||||||
MIRT264966 | TMEM136 | transmembrane protein 136 | 2 | 2 | ||||||||
MIRT267496 | FEN1 | flap structure-specific endonuclease 1 | 2 | 2 | ||||||||
MIRT285077 | MIER1 | MIER1 transcriptional regulator | 2 | 2 | ||||||||
MIRT296167 | NCOA3 | nuclear receptor coactivator 3 | 2 | 2 | ||||||||
MIRT316073 | ABRACL | ABRA C-terminal like | 2 | 2 | ||||||||
MIRT360286 | HIST1H3E | histone cluster 1 H3 family member e | 2 | 2 | ||||||||
MIRT364793 | PRRC2B | proline rich coiled-coil 2B | 2 | 2 | ||||||||
MIRT443277 | TSPAN15 | tetraspanin 15 | 2 | 2 | ||||||||
MIRT443453 | CLIC5 | chloride intracellular channel 5 | 2 | 2 | ||||||||
MIRT445938 | KLHL32 | kelch like family member 32 | 2 | 2 | ||||||||
MIRT448012 | HLA-DOA | major histocompatibility complex, class II, DO alpha | 2 | 2 | ||||||||
MIRT448382 | TP53INP1 | tumor protein p53 inducible nuclear protein 1 | 2 | 4 | ||||||||
MIRT448499 | RYBP | RING1 and YY1 binding protein | 2 | 2 | ||||||||
MIRT449896 | C11orf34 | placenta expressed transcript 1 | 1 | 2 | ||||||||
MIRT450457 | ZDHHC2 | zinc finger DHHC-type containing 2 | 2 | 2 | ||||||||
MIRT450849 | HTR2A | 5-hydroxytryptamine receptor 2A | 2 | 2 | ||||||||
MIRT453774 | NUCB1 | nucleobindin 1 | 2 | 10 | ||||||||
MIRT464399 | URM1 | ubiquitin related modifier 1 | 2 | 2 | ||||||||
MIRT465008 | TUBB2A | tubulin beta 2A class IIa | 2 | 8 | ||||||||
MIRT465145 | TSC22D2 | TSC22 domain family member 2 | 2 | 2 | ||||||||
MIRT467799 | SLC2A14 | solute carrier family 2 member 14 | 2 | 2 | ||||||||
MIRT472597 | NACC1 | nucleus accumbens associated 1 | 2 | 2 | ||||||||
MIRT477969 | DPM2 | dolichyl-phosphate mannosyltransferase subunit 2, regulatory | 2 | 2 | ||||||||
MIRT486586 | ZNF619 | zinc finger protein 619 | 2 | 2 | ||||||||
MIRT487739 | MICAL2 | microtubule associated monooxygenase, calponin and LIM domain containing 2 | 2 | 4 | ||||||||
MIRT492529 | PTMA | prothymosin, alpha | 2 | 6 | ||||||||
MIRT496845 | KCNIP2 | potassium voltage-gated channel interacting protein 2 | 2 | 2 | ||||||||
MIRT499064 | CTBP1 | C-terminal binding protein 1 | 2 | 4 | ||||||||
MIRT502046 | LAMTOR1 | late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 | 2 | 6 | ||||||||
MIRT503907 | ZSCAN25 | zinc finger and SCAN domain containing 25 | 2 | 2 | ||||||||
MIRT506776 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT510003 | UCP1 | uncoupling protein 1 | 2 | 6 | ||||||||
MIRT513040 | BRIX1 | BRX1, biogenesis of ribosomes | 2 | 2 | ||||||||
MIRT513174 | MOAP1 | modulator of apoptosis 1 | 2 | 6 | ||||||||
MIRT517592 | ZNF579 | zinc finger protein 579 | 2 | 4 | ||||||||
MIRT521825 | POLR1D | RNA polymerase I subunit D | 2 | 2 | ||||||||
MIRT530663 | TRIM56 | tripartite motif containing 56 | 2 | 2 | ||||||||
MIRT531718 | TARS | threonyl-tRNA synthetase | 2 | 2 | ||||||||
MIRT535154 | PLEKHG5 | pleckstrin homology and RhoGEF domain containing G5 | 2 | 2 | ||||||||
MIRT536385 | LEFTY1 | left-right determination factor 1 | 2 | 2 | ||||||||
MIRT543847 | APIP | APAF1 interacting protein | 2 | 2 | ||||||||
MIRT546973 | PRKAB2 | protein kinase AMP-activated non-catalytic subunit beta 2 | 2 | 2 | ||||||||
MIRT548667 | CSRNP3 | cysteine and serine rich nuclear protein 3 | 2 | 2 | ||||||||
MIRT548799 | CLIP4 | CAP-Gly domain containing linker protein family member 4 | 2 | 4 | ||||||||
MIRT549610 | TMEM101 | transmembrane protein 101 | 2 | 2 | ||||||||
MIRT549716 | NUP37 | nucleoporin 37 | 2 | 4 | ||||||||
MIRT549873 | ZNF260 | zinc finger protein 260 | 2 | 2 | ||||||||
MIRT555383 | PPP1CC | protein phosphatase 1 catalytic subunit gamma | 2 | 2 | ||||||||
MIRT566976 | LBR | lamin B receptor | 2 | 2 | ||||||||
MIRT568052 | CHSY1 | chondroitin sulfate synthase 1 | 2 | 2 | ||||||||
MIRT570970 | TMBIM4 | transmembrane BAX inhibitor motif containing 4 | 2 | 2 | ||||||||
MIRT571174 | ZNF85 | zinc finger protein 85 | 2 | 2 | ||||||||
MIRT571364 | ZNF45 | zinc finger protein 45 | 2 | 2 | ||||||||
MIRT572309 | LSM4 | LSM4 homolog, U6 small nuclear RNA and mRNA degradation associated | 2 | 2 | ||||||||
MIRT572493 | BTN2A2 | butyrophilin subfamily 2 member A2 | 2 | 2 | ||||||||
MIRT606783 | KIAA0040 | KIAA0040 | 2 | 5 | ||||||||
MIRT607952 | NFAM1 | NFAT activating protein with ITAM motif 1 | 2 | 10 | ||||||||
MIRT609978 | HERPUD2 | HERPUD family member 2 | 2 | 2 | ||||||||
MIRT610069 | CD300E | CD300e molecule | 2 | 2 | ||||||||
MIRT610118 | IL17REL | interleukin 17 receptor E like | 2 | 2 | ||||||||
MIRT610151 | PRMT8 | protein arginine methyltransferase 8 | 2 | 4 | ||||||||
MIRT611075 | ZNF621 | zinc finger protein 621 | 2 | 2 | ||||||||
MIRT612011 | COX17 | COX17, cytochrome c oxidase copper chaperone | 2 | 2 | ||||||||
MIRT617901 | PTCHD3 | patched domain containing 3 | 2 | 2 | ||||||||
MIRT618052 | MRVI1 | murine retrovirus integration site 1 homolog | 2 | 2 | ||||||||
MIRT619526 | ZNF74 | zinc finger protein 74 | 2 | 2 | ||||||||
MIRT624276 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | 2 | 2 | ||||||||
MIRT625357 | MGLL | monoglyceride lipase | 2 | 2 | ||||||||
MIRT626756 | NDUFA9 | NADH:ubiquinone oxidoreductase subunit A9 | 2 | 2 | ||||||||
MIRT628851 | FAM151B | family with sequence similarity 151 member B | 2 | 2 | ||||||||
MIRT630458 | GMPS | guanine monophosphate synthase | 2 | 2 | ||||||||
MIRT634536 | MRPS17 | mitochondrial ribosomal protein S17 | 2 | 2 | ||||||||
MIRT638806 | DCTN3 | dynactin subunit 3 | 2 | 2 | ||||||||
MIRT647607 | TMTC2 | transmembrane and tetratricopeptide repeat containing 2 | 2 | 2 | ||||||||
MIRT650885 | PPP1R15A | protein phosphatase 1 regulatory subunit 15A | 2 | 2 | ||||||||
MIRT653507 | SLC43A2 | solute carrier family 43 member 2 | 2 | 2 | ||||||||
MIRT658608 | ENTPD5 | ectonucleoside triphosphate diphosphohydrolase 5 | 2 | 2 | ||||||||
MIRT666345 | SKAP2 | src kinase associated phosphoprotein 2 | 2 | 2 | ||||||||
MIRT693743 | ACACA | acetyl-CoA carboxylase alpha | 2 | 2 | ||||||||
MIRT704049 | EDEM3 | ER degradation enhancing alpha-mannosidase like protein 3 | 2 | 2 | ||||||||
MIRT709789 | CYBRD1 | cytochrome b reductase 1 | 2 | 2 | ||||||||
MIRT711837 | AMOTL2 | angiomotin like 2 | 2 | 2 | ||||||||
MIRT711875 | VASP | vasodilator stimulated phosphoprotein | 2 | 2 | ||||||||
MIRT717349 | RAB40A | RAB40A, member RAS oncogene family | 2 | 2 | ||||||||
MIRT717746 | MYLK | myosin light chain kinase | 2 | 2 | ||||||||
MIRT725398 | LRIG2 | leucine rich repeats and immunoglobulin like domains 2 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|